Cheng-cheng Fu
Suzhou, 215008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Analysis of Clinical Features of Newly Diagnosed Multiple Myeloma Complicated with Light Chain Amyloidosis
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 03, 2026
Validation of the Predictive Ability of IMWG, IMPEDE and SAVED Thrombosis Risk Stratification Systems for Venous Thromboembolism in Chinese Multiple Myeloma Patients
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 03, 2026
Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: March 18, 2026
Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma.
Journal: Experimental hematology & oncology
Published: May 16, 2025
Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 25, 2024
Autologous stem cell transplantation in multiple myeloma patients with renal impairment.
Journal: Annals of hematology
Published: August 26, 2022
Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study.
Journal: EClinicalMedicine
Published: July 13, 2022
The Role of Whole Body DWI in the Evaluation of Bone Disease in Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 09, 2022
Interpretation of ASTCT Consensus Responses by Chimeric Antigen Receptor T Cell Therapy CRS/ICANS--Review
Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 11, 2021
Application of Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 11, 2021
The Effects of Chidamide Combined with Anti-myeloma Drugs on the Proliferation and Apoptosis of Myeloma Cells
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 07, 2021
Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
Journal: Journal of cancer research and clinical oncology
Published: November 18, 2020
Last Updated: 09/26/2026